Multiple myeloma trials in Israel
35 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 1RecruitingTrial-stage medicine
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
- Where
- Haifa, Jerusalem, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 276 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06768489EU 2024-515316-44-00Registry updated 2026-09-25
Phase 3RecruitingTrial-stage medicine
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Ashdod, Haifa, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07518186Registry updated 2026-09-25
No phaseRecruitingResearch participation
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
- Where
- Jerusalem, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Janssen-Cilag Ltd.
See details and how to joinNCT06285318Registry updated 2026-08-28
Phase 3RecruitingTrial-stage medicine
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Where
- Beersheba, Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 492 worldwide
- Run by
- Pfizer
See details and how to joinNCT06152575EU 2023-507871-23-00Registry updated 2026-08-24
Phase 1/2RecruitingTrial-stage medicine
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- Where
- Beersheba, Jerusalem, Ramat Gan
- Age
- 18 years and over
- People
- 123 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05714839EU 2022-501941-63-00Registry updated 2026-08-19
No phaseRecruitingResearch participation
Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population
- Where
- Beersheba, Haifa, Petah Tikva, Tel Aviv
- Age
- 30 years and over
- People
- 2,000
- Run by
- Tel-Aviv Sourasky Medical Center
See details and how to joinNCT05837884Registry updated 2026-08-11
Phase 1RecruitingTrial-stage medicine
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Jerusalem, Petah Tikva, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 210 worldwide
- Run by
- AbbVie
See details and how to joinNCT05650632EU 2023-504674-38-00Registry updated 2026-07-13
Phase 3RecruitingTrial-stage medicine
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Beersheba, Jerusalem, Koranit, Petah Tikva, Tel Aviv
- Age
- 18 years and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101EU 2024-516030-35-00Registry updated 2026-04-22
Phase 1RecruitingTrial-stage medicine
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
- Where
- Haifa, Jerusalem, Tel Aviv
- Age
- 18 years and over
- People
- 87 worldwide
- Run by
- Sanofi
See details and how to joinNCT06630806Registry updated 2026-03-25
Phase 1/2RecruitingTrial-stage medicine
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
- Where
- Ramat Gan
- Age
- 18 years and over
- People
- 75
- Run by
- Sheba Medical Center
See details and how to joinNCT05243212Registry updated 2024-01-31
All Multiple myeloma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.